Carl Gustav Carus University Hospital, Dresden – Germany
About Prof. Dr. med. Mechthild Krause
Prof. Dr. med. Mechthild Krause is one of Germany's most distinguished Radiation Oncologists with over 12 years of experience. She is Director of OncoRay (HZDR Institute of Radiooncology), Director of NCT/UCC Dresden, Chair of the Department of Radiation Oncology at TU Dresden University Hospital, and a winner of both the VARIAN-Juliana Denekamp Award (ESTRO 2005) and the Hermann Holthusen Award (DEGRO).
- 12+ years of experience in Radiation Oncology and Translational Radiooncology Research
- Medical Graduation and Dr. med. — Technische Universität (TU) Dresden, Germany
- Professor for Translational Radiation Oncology at TU Dresden (since 2016)
- Director — OncoRay (HZDR), Chair Department of Radiation Oncology at UKD, Executive Director NCT Dresden
- Winner — VARIAN-Juliana Denekamp Award (ESTRO 2005) and Hermann Holthusen Award (DEGRO)
Qualifications & Credentials
Medical Degrees
- Medical Graduation — Technische Universität (TU) Dresden, Germany
- Dr. med. — Technische Universität (TU) Dresden, Germany
- Habilitation in Radiation Oncology — TU Dresden, Germany
Fellowships & Special Training
- Specialist Radiotherapy (Facharzt für Strahlentherapie) — Department of Radiation Oncology, University Hospital Carl Gustav Carus, Dresden (2007–2009)
- Visiting Scientist — Princess Margaret Hospital, Toronto, Canada (April–October 2007)
- Group Leader — Experimental Radiotherapy, Department of Radiation Oncology, UKD (2006–2007)
- Specialised training in particle (proton) radiotherapy
- Specialised training in biologically individualised radiation therapy
Certifications & Accreditations
- German Medical Council (Sächsische Landesärztekammer) Registration
- European Society for Radiotherapy and Oncology (ESTRO) — Member
- German Society of Radiation Oncology (DEGRO) — Member
- German Cancer Consortium (DKTK) — Spokesperson, Dresden Partner Site
- Member of Editorial Board — Strahlentherapie und Onkologie
Areas of Expertise
Major Conditions Treated
- Brain Tumours (Glioma, Meningioma, Metastases)
- Breast Cancer
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung Cancer
- Prostate Cancer
- Cervical Cancer
- Rectal Cancer
- Pancreatic Cancer
- Sarcoma
- Paediatric Cancers (Radiation indications)
- Recurrent Tumours after Prior Radiotherapy
- Tumours requiring Particle (Proton) Therapy
- Cancer Stem Cell-Driven Radioresistant Tumours
Sub-specialties
- Brain Tumour & Breast Tumour Radiation Therapy: Comprehensive image-guided and biologically individualised radiation therapy for brain tumours and breast tumours — a leading Radiation Oncologist specialist in Dresden, Germany for international patients.
- Particle (Proton) Radiotherapy & Translational Radiooncology: Director of OncoRay — National Center for Radiation Research in Oncology (joint with Heidelberg HIRO), pioneering particle / proton radiotherapy and biologically individualised radiotherapy.
- Cancer Stem Cell-Targeted Radiotherapy & Biomarker-Driven Care: Pioneering work on cancer stem cell biomarkers and tumour hypoxia imaging (FMISO-PET) for radioresistance prediction — relevant for international patients researching the best radiation oncologist in Germany.
Advanced Procedures & Treatments
- Image-Guided Radiation Therapy (IGRT)
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Radiosurgery (SRS)
- Stereotactic Body Radiation Therapy (SBRT)
- Particle (Proton) Radiotherapy
- Radio-Chemotherapy (Combined Modality)
- Postoperative Radio(chemo)therapy
- Hypoxia Imaging (FMISO-PET) Guided Radiation
- Biologically Individualised Radiation Therapy
- Cancer Stem Cell-Targeted Radiotherapy Strategies
- Multidisciplinary Tumour Board Coordination
List of Disease and Treatment for which Prof. Dr. med. Mechthild Krause can be consulted
Professional Experience
Current Affiliation
- Director — Institute of Radiooncology – OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany (Present)
- Director — OncoRay, National Center for Radiation Research in Oncology, Dresden (Present)
- Chair — Department of Radiation Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus (UKD), TU Dresden, Fetscherstraße, Dresden, Germany (Present)
- Executive Director — National Center for Tumor Diseases (NCT) Dresden (Present)
- Spokesperson — DKTK (German Cancer Consortium) Partner Site Dresden, DKFZ (Present)
- Professor for Translational Radiation Oncology — TU Dresden (since 2016)
Past Affiliations
- Deputy Spokesperson — DKTK Partner Site Dresden (2015–2016)
- Vice Chair — Department of Radiation Oncology, UKD (2012–2016)
- Senior Physician / Responsible Medical Specialist — Department of Radiation Oncology, UKD (2010–2012)
- Specialist Radiotherapy — Department of Radiation Oncology, UKD (2007–2009)
- Visiting Scientist — Princess Margaret Hospital, Toronto, Canada (2007)
- Group Leader, Experimental Radiotherapy — Department of Radiation Oncology, UKD (2006–2007)
Academic & Research Roles
- Professor for Translational Radiation Oncology — TU Dresden (since 2016)
- Director — OncoRay Postgraduate School (Master's in Medical Radiation Sciences, doctoral programme)
- Editorial Board — Strahlentherapie und Onkologie (Journal of Radiation Oncology, Biology, Physics)
- Principal Investigator — DKTK Radiation Oncology Group (DKTK-ROG)
- Numerous publications in international high-ranking journals
Key Achievements
- 12+ years of experience in Radiation Oncology and Translational Radiooncology Research
- VARIAN-Juliana Denekamp Award — European Society for Radiotherapy Oncology (ESTRO) 2005
- Hermann Holthusen Award — German Society of Radiation Oncology (DEGRO)
- Director of OncoRay — National Center for Radiation Research in Oncology (a joint German national centre with Heidelberg HIRO)
- Chair of one of Germany's leading Radiation Oncology departments at TU Dresden
- Author of major publications on cancer stem cells, radioresistance and biomarker-driven radiotherapy
Awards & Recognitions
National & International Awards
- VARIAN-Juliana Denekamp Award — European Society for Radiotherapy Oncology (ESTRO) 2005
- Hermann Holthusen Award — German Society of Radiation Oncology (DEGRO)
- Habilitation and Professorship — Translational Radiation Oncology, TU Dresden (2016)
Professional Memberships
- European Society for Radiotherapy and Oncology (ESTRO)
- German Society of Radiation Oncology (DEGRO)
- German Cancer Consortium (DKTK) — Dresden Site Spokesperson
- Editorial Board — Strahlentherapie und Onkologie
Research & Publications
Published Papers (Selected)
- Schmidt S et al. "Development and validation of a gene signature for patients with head and neck squamous cell carcinomas treated by postoperative radio(chemo)therapy." Clinical Cancer Research, 24 (2018).
- Numerous publications in international high-ranking journals on cancer stem cells, radioresistance, hypoxia imaging (FMISO-PET) and biologically individualised radiotherapy.
Ongoing Research & Clinical Interests
- Biologically individualised radiotherapy (clinical trials and preclinical-translational studies)
- Particle (proton) radiotherapy evaluation
- Cancer stem cells and radioresistance
- Hypoxia imaging (FMISO-PET) and tumour microenvironment
- Biomarker-driven radiotherapy for HNSCC and other cancers
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Radiation Oncology Consultation | €450 – €750 | $486 – $810 |
| Image-Guided Radiation Therapy (IGRT) Course | €8,500 – €18,000 | $9,180 – $19,440 |
| IMRT Course (Multi-Session) | €10,000 – €22,000 | $10,800 – $23,760 |
| Stereotactic Radiosurgery (SRS / SBRT) | €8,000 – €16,000 | $8,640 – $17,280 |
| Proton Therapy Course | €25,000 – €60,000 | $27,000 – $64,800 |
| Combined Radio-Chemotherapy | €18,000 – €40,000 | $19,440 – $43,200 |
| Brain Tumour Radiation Package | €15,000 – €35,000 | $16,200 – $37,800 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Mechthild Krause use in Radiation Oncologist treatment?
Prof. Dr. med. Mechthild Krause uses the most advanced radiation oncology technologies including image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS) and SBRT, particle (proton) radiotherapy via OncoRay, biologically individualised radiation therapy, hypoxia imaging (FMISO-PET) guided radiation, and cancer stem cell-targeted radiotherapy strategies. Virtual second opinions are also available for international patients.
2. What conditions does Prof. Dr. med. Mechthild Krause specialize in treating?
Prof. Dr. med. Mechthild Krause specialises in brain tumours (glioma, meningioma, metastases), breast cancer, head and neck squamous cell carcinoma, lung cancer, prostate cancer, cervical cancer, rectal cancer, pancreatic cancer, sarcoma, paediatric cancers (radiation indications), recurrent tumours after prior radiotherapy, tumours requiring proton therapy, and cancer stem cell-driven radioresistant tumours — making her a leading Radiation Oncologist specialist in Dresden, Germany.
3. How do I book an appointment with Prof. Dr. med. Mechthild Krause?
Appointments with Prof. Dr. med. Mechthild Krause can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Mechthild Krause?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Mechthild Krause, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. med. Mechthild Krause offer second opinions for Radiation Oncologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with the Director of OncoRay and Chair of Radiation Oncology at TU Dresden — particularly relevant for brain tumour, breast tumour, head and neck cancer, proton therapy and recurrent / radioresistant tumour cases.
Carl Gustav Carus University Hospital, Dresden - Germany
